| Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992) |
|---|
| 07/20/2005 | CN1643141A Saccharomyces cerevisiae yeast strain with improved phytase activity |
| 07/20/2005 | CN1643138A Novel cytokine ZCYTOR17 ligand |
| 07/14/2005 | WO2005037997A3 Competition assay for identifying modulators of quadruplex nucleic acids |
| 07/14/2005 | WO2005033274A3 A process for producing exogenous protein in the milk of trangenic mammals and a process for purifying proteins therefrom |
| 07/14/2005 | WO2005026324A3 Method and composition for enhancing in vitro embryo development by supplementing culture medium with prostaglandin or a prostaglandin analog |
| 07/14/2005 | WO2005023990A3 Trans-splicing mediated photodynamic therapy |
| 07/14/2005 | WO2005012502A3 Methods of identifying optimal variants of peptide epitopes |
| 07/14/2005 | WO2005010149A3 Subgroup b adenoviral vectors for treating disease |
| 07/14/2005 | WO2005001063A3 Polynucleotides capable of target-dependent circularization and topological linkage |
| 07/14/2005 | WO2004101747A3 Identification and use of gpr54 and its ligands for reproductive disorders and contraception |
| 07/14/2005 | WO2004078939A3 REGULATION OF Mdm2 FUNCTION |
| 07/14/2005 | US20050155095 Porcine Isogloboside 3 synthase protein, cDNA, genomic organization, and regulatory region |
| 07/14/2005 | US20050153887 Compositions for inducing cell growth and differentiation and methods of using same |
| 07/14/2005 | US20050153425 analysis apparatus comprising electrode layouts on nonconducting substrates, impedance analyzers and software programs, used for analyzing cells; screening compounds that effect immunoglobulin mediated responses of cells to antigens |
| 07/14/2005 | US20050153337 iRNA conjugates |
| 07/14/2005 | US20050153328 Method and markers for determining the genotype of horned/polled cattle |
| 07/14/2005 | US20050153319 Estrogen receptor gene variation and disease |
| 07/14/2005 | US20050153316 Methods for quantitative determination of methylation density in a DNA locus |
| 07/14/2005 | US20050153287 Nr3b nmda receptor subunit compositions and related methods |
| 07/14/2005 | US20050152908 Expressed in blood and useful in diagnosing liver cancer as well as monitoring therapeutic efficacy; polynucleotides; eg amyloid beta (A4) precursor-like protein 2 (APLP2); BCL2-related protein A1 (BCL2A1) |
| 07/13/2005 | EP1552022A2 Identification of oligonucleotides for the capture, detection and quantitation of hepatitis a viral nucleic acid |
| 07/13/2005 | EP1552010A2 Strategies for gene expression analysis |
| 07/13/2005 | CN1639352A Amplifying repetitive nucleic acid sequences |
| 07/12/2005 | US6916904 Inhibition of immune complex formation |
| 07/12/2005 | US6916474 Binds immunologically to bacillus anthracis protective antigen with an affinity kd of 140-21 pm determined by surface plasmon resonance |
| 07/07/2005 | WO2005047482A3 Real time electronic cell sensing systems and applications for cell-based assays |
| 07/07/2005 | WO2005042693A3 Hla-e chimeric molecule |
| 07/07/2005 | WO2005038006A3 Chimeric metabotropic glutamate receptors and uses thereof |
| 07/07/2005 | WO2005038003A3 Compositions and methods for generation of positive and negative selection vectors |
| 07/07/2005 | WO2005035729A3 A genetic screen in drosophila for metastatic behavior |
| 07/07/2005 | WO2005035720A3 Methods and use of binding components for improving assay specificity |
| 07/07/2005 | WO2005033284A3 Compositions and methods for gene expression |
| 07/07/2005 | WO2005023979A3 Isolated s. mansoni nucleic acid molecules and uses thereof |
| 07/07/2005 | WO2005019419A3 Co-detection of single polypeptide and polynucleotide molecules |
| 07/07/2005 | WO2005017095A3 A stable liquid probiotic composition, preparation and applications thereof |
| 07/07/2005 | WO2005014798A3 Novel compositions and methods for promoting, inhibiting, and detecting protein entry into cells |
| 07/07/2005 | WO2005003293A3 pRNA CHIMERA |
| 07/07/2005 | WO2004099364A3 Multicellular compositions of pluripotent human embryonic stem cells and cancer cells |
| 07/07/2005 | WO2004078909A3 Identification of antigen epitopes |
| 07/07/2005 | US20050149993 Transgenic mouse for use as model in identifying modulators for prevention and treatment of circadian rythm disorders |
| 07/07/2005 | US20050148533 Modulation of RANKL expression |
| 07/07/2005 | US20050148527 Catalytic nucleic acids; ribozymes; translation inhibition; gene expression inhibition; for treating cardiovascular disease; for neovascularization induction in heart tissue |
| 07/07/2005 | US20050148070 Propagating human progenitor cell using nutrient broth free of mammalian fetal serum; tissue engineering; regenerative medicine |
| 07/07/2005 | US20050148069 IGF-1 instructs multipotent adult CNS neural stem cells to an oligodendroglial lineage |
| 07/07/2005 | US20050148045 Using transgenic microorganism comprising gene coding fostriecin polyketide synthase to generates antitumor antibiotics; bioreactors; anticarcinogenic agents |
| 07/07/2005 | US20050148030 Using computer generated models to design immunoglobulin specific ligands; immunosuppressants; rational drug design |
| 07/07/2005 | US20050147993 Recombinant high mobility polypeptide comprisingprotein transduction domain linked to non-nuclear organelle targeting signal; gene transfer vector |
| 07/07/2005 | US20050147960 Propagating multipotent cells on biological scaffold in presence of cell growth factor and determining and/or screening for controlled development, self-assembly or differentiation; regenerative medicine; tissue engineering |
| 07/07/2005 | US20050147618 comprising blood coagulation factors and segments of an immunoglobulin fragments, used for treating hemostatic disorders |
| 07/07/2005 | US20050147608 modulating the activity of a nuclear factor kappa beta (NF-kB) polypeptide in cells by contacting with phosphoserine peptide or mimetics, for the treatment of cell proliferative disorders, immune response disorders and inflammatory disorders |
| 07/06/2005 | EP1549772A2 Methods and compositions for detection and analysis of polynucleotides using light harvesting multichromophores |
| 07/06/2005 | CN1636229A Compositions and methods for priming monocytic dendritic cells and T cells for TH-1 response |
| 07/06/2005 | CN1636067A TACIs and BR3 polypeptides and uses thereof |
| 06/30/2005 | WO2005059156A2 Nucleic acid probes and broad-range primers from regions in dna directed rna polymerase subunit b genes, and methods in which they are used |
| 06/30/2005 | WO2005059111A2 DELIVERY OF DNA OR RNA VIA GAP JUNCTIONS FROM HOST CELLS TO TARGET CELLS AND A CELL-BASED DELIVERY SYSTEM FOR ANTISENSE OR SiRNA |
| 06/30/2005 | WO2005059110A2 Methods and materials for canine breed identification |
| 06/30/2005 | WO2005059109A2 Molecular signature of the pten tumor suppressor |
| 06/30/2005 | WO2005059108A2 Gene expression profiles and methods of use |
| 06/30/2005 | WO2005059107A2 Chemokine receptor binding compounds |
| 06/30/2005 | WO2005059106A2 Interferon alpha antibodies and their uses |
| 06/30/2005 | WO2005059105A2 Cdk5 genetic markers associated with galantamine response |
| 06/30/2005 | WO2005059104A2 Slc5a7 genetic markers associated with age of onset of alzheimer's disease |
| 06/30/2005 | WO2005059103A2 Corn plant mon88017 and compositions and methods for detection thereof |
| 06/30/2005 | WO2005059101A2 Novel sodium channel |
| 06/30/2005 | WO2005059100A2 Methods and compositions relating to cystatin c |
| 06/30/2005 | WO2005059099A2 Human ipla2t |
| 06/30/2005 | WO2005059098A2 Methods and compositions for treating and/or preventing neurodegenerative conditions |
| 06/30/2005 | WO2005059097A2 Methods for high fidelity production of long nucleic acid molecules |
| 06/30/2005 | WO2005059096A2 Methods for high fidelity production of long nucleic acid molecules with error control |
| 06/30/2005 | WO2005059095A2 Expansion and differentiation of islet progenitor cells |
| 06/30/2005 | WO2005059093A2 P ef-tu expression units |
| 06/30/2005 | WO2005044989A3 Polynucleotides and polypeptides of anaplasma phagocytophilum and methods of using the same |
| 06/30/2005 | WO2005044973A3 NOVEL ACETOACETYL-CoA REDUCTASE AND PROCESS FOR PRODUCING OPTICALLY ACTIVE ALCOHOL |
| 06/30/2005 | WO2005042704A3 Differential enzymatic fragmentation |
| 06/30/2005 | WO2005040357A3 Compounds and methods for fluorescent labeling |
| 06/30/2005 | WO2005032475A3 In vivo efficacy of ny-eso-1 plus adjuvant |
| 06/30/2005 | WO2005028617A3 Antisense inhibition of laminin-8 expression to inhibit human gliomas |
| 06/30/2005 | WO2005026315A3 Method for producing insulin from a natural source and insulin |
| 06/30/2005 | WO2005023988A3 Modulation of cell intrinsic strain to control matrix synthesis, secretion, organization and remodeling |
| 06/30/2005 | WO2005021725A3 Nucleic acid analysis method conducted in small reaction volumes |
| 06/30/2005 | WO2005017093A3 Polypeptides of streptococcus pyogenes |
| 06/30/2005 | WO2005014784B1 System for molecular imaging |
| 06/30/2005 | WO2005001056A3 Methods for controlling catalase |
| 06/30/2005 | WO2004111184A3 Method of amplifying metabolically inactive bacteria |
| 06/30/2005 | WO2004099385A3 Telomere elongation |
| 06/30/2005 | WO2004083401A3 Broken cell wall chlorella and process for preparation thereof |
| 06/30/2005 | WO2004076640A3 Small-molecule inhibitors of angiogenin and rnases and in vivo and in vitro methods of using same |
| 06/30/2005 | WO2004074452A3 Multiplex mapping of protein interactions |
| 06/30/2005 | WO2004072230A3 Real-time polymerase chain reaction using large target amplicons |
| 06/30/2005 | WO2003062389A3 UNIVERSAL RT-COUPLED PCR METHOD FOR THE SPECIFIC AMPLIFICATION OF mRNA |
| 06/30/2005 | US20050144671 Snow1: interacts with Ice1 and regulates CBF expression and freezing tolerance in arabidopsis |
| 06/30/2005 | US20050143316 Hepatitis C virus inhibitors |
| 06/30/2005 | US20050143287 Ischemic heart disease, critical limb ischemia, wound healing and burns, cancer, diabetic retinopathy, and inflammatory diseases such as arthritis and psoriasis |
| 06/30/2005 | US20050142658 Chromosomal saturation mutagenesis |
| 06/30/2005 | US20050142637 Long-wavelength FPs |
| 06/30/2005 | US20050142617 gene related to bone density; possible use in the drug screening, treatment, and diagnosis of bone disorders such as osteoporosis |
| 06/30/2005 | US20050142610 domains peptides having increased or decreased binding specificity for phosphatides, used as controls in bioassays to detect the presence of specific phosphatides |
| 06/30/2005 | US20050142609 Native immunoglobulin binding reagents and methods for making and using same |
| 06/30/2005 | US20050142607 Contacting biological sample with at least two antibodies wherein epitope in Moraxella catarrhalis for each antibody is either internal or surface exposed and detecting binding of antibodies to sample, wherein binding is indicative of presence of Moraxella catarrhalis; bacteria-induced acute otitis media |
| 06/30/2005 | US20050142595 Analyzing nucleic acid by contacting with intercalator fluorophore and sequence specific probe capable of hybridizing to nucleic acid, wherein probe is labeled with probe fluorophore, and detecting fluorescence resonance energy transfer between intercalator fluorophore and probe fluorophore |